A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Stanford University
PMV Pharmaceuticals, Inc
Fred Hutchinson Cancer Center
Mayo Clinic
Eli Lilly and Company
Mayo Clinic
University Hospital Heidelberg
BicycleTx Limited
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
Ankyra Therapeutics, Inc
N-Power Medicine
M.D. Anderson Cancer Center
ViroMissile, Inc.
Eli Lilly and Company
Astellas Pharma Inc
Avenzo Therapeutics, Inc.
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Mirati Therapeutics Inc.
InSilico Medicine Hong Kong Limited
ALX Oncology Inc.
Clasp Therapeutics, Inc.
Eli Lilly and Company
NiKang Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
DualityBio Inc.
Kyowa Kirin Co., Ltd.
Pfizer
Eli Lilly and Company
Kidney Cancer Research Bureau
IDEAYA Biosciences
Plexium, Inc.
NRG Oncology
Mayo Clinic
GlaxoSmithKline
Sairopa B.V.
NovoCure Ltd.
Memorial Sloan Kettering Cancer Center
VM Oncology, LLC
AstraZeneca